Indian gov hits back at drug quality critics by Nick Taylor

Newsroom

IP News

The Indian Department of Commerce has published a 1,000 word riposte to the drug quality furore sparked by the Ranbaxy scandal. In the statement, the Indian government defends its record on drug quality and regulation, citing a slew of statistics and initiatives to support its argument. The release was prompted by ‘extensive media reporting’ on Indian drugs, much of which stemmed from the Fortune exposé of Ranbaxy. Read more

~back to News Center~

Print Friendly, PDF & Email
FILE A TRADEMARK